Citizens & Northern Corp Abbott Laboratories Transaction History

Citizens & Northern Corp

$331 Million
Q3 2024

A detailed history of Citizens & Northern Corp transactions in Abbott Laboratories stock. As of the latest transaction made, Citizens & Northern Corp holds 21,576 shares of ABT stock, worth $2.42 Million. This represents 0.74% of its overall portfolio holdings.

Number of Shares

21,576

Previous 20,007 7.84%

Holding current value

$2.42 Million

Previous $2.08 Million 18.33%

% of portfolio

0.74%

Previous 0.65%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 04, 2024	BUY	$100.07 - $118.13 $157,009 - $185,345	1,569 Added 7.84%	21,576 $2.46 Million
Q2 2024 Jul 30, 2024	SELL	$100.73 - $112.44 $96,398 - $107,605	-957 Reduced 4.56%	20,007 $2.08 Million
Q1 2024 May 13, 2024	SELL	$109.52 - $120.96 $148,618 - $164,142	-1,357 Reduced 6.08%	20,964 $2.38 Million
Q4 2023 Feb 09, 2024	SELL	$90.19 - $110.4 $87,574 - $107,198	-971 Reduced 4.17%	22,321 $2.46 Million
Q3 2023 Nov 13, 2023	SELL	$95.53 - $114.62 $1,528 - $1,833	-16 Reduced 0.07%	23,292 $2.26 Million
Q2 2023 Aug 11, 2023	SELL	$100.78 - $112.29 $580,593 - $646,902	-5,761 Reduced 19.82%	23,308 $2.54 Million
Q1 2023 May 05, 2023	BUY	$96.86 - $114.01 $18,112 - $21,319	187 Added 0.65%	29,069 $2.94 Million
Q4 2022 Feb 14, 2023	BUY	$95.06 - $111.52 $81,466 - $95,572	857 Added 3.06%	28,882 $3.17 Million
Q3 2022 Nov 09, 2022	BUY	$96.76 - $112.03 $3,289 - $3,809	34 Added 0.12%	28,025 $2.71 Million
Q2 2022 Aug 04, 2022	SELL	$102.07 - $123.37 $73,184 - $88,456	-717 Reduced 2.5%	27,991 $3.04 Million
Q1 2022 May 12, 2022	SELL	$114.02 - $139.04 $94,864 - $115,681	-832 Reduced 2.82%	28,708 $3.4 Million
Q4 2021 Jan 24, 2022	SELL	$115.53 - $141.46 $85,030 - $104,114	-736 Reduced 2.43%	29,540 $4.16 Million
Q3 2021 Nov 04, 2021	SELL	$116.66 - $129.06 $161,224 - $178,360	-1,382 Reduced 4.37%	30,276 $3.58 Million
Q2 2021 Aug 02, 2021	SELL	$105.79 - $124.53 $216,234 - $254,539	-2,044 Reduced 6.06%	31,658 $3.67 Million
Q1 2021 May 11, 2021	BUY	$108.84 - $128.23 $83,589 - $98,480	768 Added 2.33%	33,702 $4.04 Million
Q4 2020 Feb 09, 2021	BUY	$105.0 - $114.42 $2,520 - $2,746	24 Added 0.07%	32,934 $3.61 Million
Q3 2020 Nov 13, 2020	SELL	$91.64 - $111.29 $95,488 - $115,964	-1,042 Reduced 3.07%	32,910 $3.58 Million
Q2 2020 Aug 07, 2020	SELL	$76.57 - $98.0 $124,655 - $159,544	-1,628 Reduced 4.58%	33,952 $3.1 Million
Q1 2020 May 08, 2020	BUY	$62.82 - $91.86 $50,507 - $73,855	804 Added 2.31%	35,580 $2.81 Million
Q4 2019 Feb 11, 2020	SELL	$78.51 - $87.4 $75,840 - $84,428	-966 Reduced 2.7%	34,776 $3.02 Million
Q3 2019 Nov 12, 2019	SELL	$81.84 - $88.74 $57,779 - $62,650	-706 Reduced 1.94%	35,742 $2.99 Million
Q2 2019 Aug 14, 2019	SELL	$72.88 - $85.0 $131,912 - $153,850	-1,810 Reduced 4.73%	36,448 $3.07 Million
Q1 2019 May 13, 2019	BUY	$66.22 - $80.06 $509,562 - $616,061	7,695 Added 25.18%	38,258 $3.06 Million
Q4 2018 Feb 14, 2019	SELL	$65.56 - $74.27 $26,617 - $30,153	-406 Reduced 1.31%	30,563 $2.21 Million
Q3 2018 Nov 14, 2018	SELL	$60.81 - $73.36 $50,533 - $60,962	-831 Reduced 2.61%	30,969 $2.27 Million
Q2 2018 Aug 03, 2018	BUY	$57.57 - $63.54 $24,064 - $26,559	418 Added 1.33%	31,800 $1.94 Million
Q1 2018 May 14, 2018	BUY	$56.27 - $63.62 $225 - $254	4 Added 0.01%	31,382 $1.88 Million
Q4 2017 Feb 14, 2018	BUY	$53.68 - $57.47 $32,046 - $34,309	597 Added 1.94%	31,378 $1.79 Million
Q3 2017 Nov 13, 2017	BUY	$48.06 - $53.64 $18,887 - $21,080	393 Added 1.29%	30,781 $1.64 Million
Q2 2017 Aug 11, 2017	BUY	N/A	30,388	30,388 $1.48 Million

Others Institutions Holding ABT

# of Institutions

3,189

Shares Held

1.3B

Call Options Held

8.74M

Put Options Held

8.08M

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $197B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Citizens & Northern Corp, based on Form 13F filings with the SEC.

News

Stay updated on Citizens & Northern Corp with notifications on news.

Account

Citizens & Northern Corp Abbott Laboratories Transaction History